Maze Therapeutics Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Maze Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $62.55. The average 1-year stock price forecast is 134.53% higher than the current stock price, while the lowest is $46 (+72.48%) and the highest is $110 (+312.45%).

Price Target: $62.55 (+134.53%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$46	$62.55	$55	$110
Change	+72.48%	+134.53%	+106.22%	+312.45%

* Price targets were last updated on May 23, 2026.

Analyst Ratings

The average analyst rating for Maze Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	9	9	9	11	11	11
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	12	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Anupam Rama J.P. Morgan	J.P. Morgan	Buy Maintains $58 → $53	Buy	Maintains	$58 → $53	+98.73%	May 23, 2026
Ananda Ghosh H.C. Wainwright	H.C. Wainwright	Buy Maintains $110	Buy	Maintains	$110	+312.45%	May 20, 2026
Rami Katkhuda LifeSci Capital	LifeSci Capital	Buy Maintains $57	Buy	Maintains	$57	+113.72%	May 16, 2026
Danielle Brill Truist Financial	Truist Financial	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 14, 2026
Sadia Rahman Wells Fargo	Wells Fargo	Buy Maintains $55	Buy	Maintains	$55	+106.22%	May 14, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

18.18M

Revenue Next Year

8.85M

from 18.18M

-51.35%

from 18.18M

EPS This Year

-2.77

from -3.05

EPS Next Year

-3.31

from -2.77

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	167.50M	-	18.18M
Gross Profit	-	-	167.50M	-	18.18M
Gross Margin	-	-	100.00%	-	100.00%
Operating Income	-111.03M	-98.55M	57.59M	-142.90M	-171.24M
Net Income	-114.94M	-100.42M	52.23M	-131.12M	-157.95M
EPS	-	-	-	-3.05	-2.77
Free Cash Flow	-	-52.55M	52.09M	-72.52M	-153.99M
No. Analysts	-	-	-	-	11

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	40.0M
Avg	18.2M
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	230.0%
Avg	-51.4%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	-2.29
Avg	-2.77
Low	-3.07

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-